CHRISTOPHER A. SEEGER is a founding member of Seeger Weiss LLP. One of the country's most respected attorneys in the area of complex and mass tort actions, Mr. Seeger has been appointed to leadership positions in numerous state and federal actions involving pharmaceuticals, including: Vioxx, Zyprexa, Rezulin, PPA, and Ephedra.
Mr. Seeger has played significant roles in multiple pharmaceutical litigations. Most recently, Plaintiffs' lawyers unanimously selected Mr. Seeger to co-lead the federal Vioxx Litigation MDL and, on April 8, 2005, Judge Fallon affirmed that choice by appointing Mr. Seeger to co-lead the Plaintiffs' Steering Committee, and to be one of only three members of the Executive Committee. Mr. Seeger was also appointed as Liaison Counsel and Co-lead Counsel for New Jersey's Vioxx Litigation. And Mr. Seeger recently negotiated on behalf of plaintiffs, a national $700 million settlement with Eli Lilly of substantially all of the Zyprexa litigation.
In 2007, Mr. Seeger represented Frederick "Mike" Humeston and his wife Mary in the seven week jury re-trial of a Vioxx related personal injury lawsuit in Atlantic City, New Jersey. Mr. Humeston suffered a heart attack after using Vioxx for a short period. After considering the evidence, the jury returned a compensatory and punitive damages award against Merck for $47.5 million dollars. Less than a week after obtaining that verdict, Mr. Seeger argued before the New Jersey Supreme Court to defend a nationally certified class action on behalf of health insurers and union health plans against Merck who are suing to recover money paid by them for Vioxx prescriptions. Earlier, in January 2006, Mr. Seeger successfully argued Merck's appeal before the New Jersey Appellate Division, which resulted in a unaniumous March 31, 2006 decision affirming Superior Court Judge Carol E. Higbee's July 29, 2005 class certification ruling. Mr. Seeger successfully argued the class certification motion before Judge Higbeee in June 2005, along with Seeger Weiss partner David Buchanan
Mr. Seeger has played significant roles in multiple other pharmaceutical litigations. He is the principal negotiator and Co-Lead Counsel in the nationwide settlement of all PPA related injuries resulting from the ingestion of Dexatrim. He was appointed to the Plaintiffs' Steering Committee in the Rezulin MDL litigation, which is assigned to Judge Lewis A. Kaplan in the Southern District of New York. He is also a member of the Plaintiffs' Steering Committee in the Rezulin New Jersey state litigation. Mr. Seeger serves on the Plaintiffs' Steering Committee in the PPA MDL litigation pending in the Western District of Washington and the PPA New York state court litigation pending before Judge Helen Freedman in which he serves as Liaison Counsel in New York County. Additionally, Mr. Seeger is a member of the Propulsid Plaintiffs' Steering Committee in both the federal MDL litigation pending in the Eastern District of Louisiana and the New Jersey state litigation in Middlesex County. Mr. Seeger was recently appointed Liaison Counsel in the Ephedra MDL by Judge Jed S. Rakoff in the Southern District of New York
In addition to his $47.5 million verdict in Vioxx, Mr. Seeger, in March 2003, following a six-week jury trial, achieved a $2 million verdict against Pfizer on behalf of a Brooklyn resident who sustained liver injuries and was hospitalized for 10 days following her Rezulin use. The case was the first Rezulin case to be tried in New York and followed a string of Rezulin defense verdicts in other jurisdictions.
Mr. Seeger has lectured extensively on many topics involving complex litigation including state and federal coordination of multi-state and multi-jurisdictional litigation and the use of Alternative Dispute Resolution in class action and mass tort litigation. Several of Mr. Seeger's cases have received regional and national press coverage. Most recently, Mr. Seeger appeared on CNBC, Bloomberg Television and Bloomberg Radio regarding the Vioxx Litigation, and has been quoted in a variety of print media, including the Wall Street Journal, New York Times, and Fortune magazine regarding the Vioxx and Zyprexa litigation.
Mr. Seeger was born in New York, New York. He graduated from Hunter College of the City University of New York, summa cum laude, and earned his law degree from Benjamin N. Cardozo School of Law, magna cum laude. While in law school, he was the Managing Editor of the Benjamin N. Cardozo Law Review
Mr. Seeger is admitted to practice law in state courts in both New York and New Jersey as well as in the U.S. District Courts for the Eastern and Southern Districts of New York and the District of New Jersey.